These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26829100)

  • 1. Lauroyl-gemcitabine-loaded lipid nanocapsule hydrogel for the treatment of glioblastoma.
    Bastiancich C; Vanvarenberg K; Ucakar B; Pitorre M; Bastiat G; Lagarce F; Préat V; Danhier F
    J Control Release; 2016 Mar; 225():283-93. PubMed ID: 26829100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection.
    Bastiancich C; Bianco J; Vanvarenberg K; Ucakar B; Joudiou N; Gallez B; Bastiat G; Lagarce F; Préat V; Danhier F
    J Control Release; 2017 Oct; 264():45-54. PubMed ID: 28830791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug combination using an injectable nanomedicine hydrogel for glioblastoma treatment.
    Bastiancich C; Bozzato E; Luyten U; Danhier F; Bastiat G; Préat V
    Int J Pharm; 2019 Mar; 559():220-227. PubMed ID: 30703501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of lauroyl-gemcitabine-loaded hydrogel efficacy in glioblastoma rat models.
    Bastiancich C; Lemaire L; Bianco J; Franconi F; Danhier F; Préat V; Bastiat G; Lagarce F
    Nanomedicine (Lond); 2018 Aug; 13(16):1999-2013. PubMed ID: 30204064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-drug loaded nanomedicine hydrogel as a therapeutic platform to target both residual glioblastoma and glioma stem cells.
    Bozzato E; Tsakiris N; Paquot A; Muccioli GG; Bastiancich C; Préat V
    Int J Pharm; 2022 Nov; 628():122341. PubMed ID: 36341916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioblastoma-targeted, local and sustained drug delivery system based on an unconventional lipid nanocapsule hydrogel.
    Gazaille C; Bozzato E; Madadian-Bozorg N; Mellinger A; Sicot M; Farooq U; Saulnier P; Eyer J; Préat V; Bertrand N; Bastiat G
    Biomater Adv; 2023 Oct; 153():213549. PubMed ID: 37453243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of the effectiveness of poly(ε-caprolactone) lipid-core nanocapsules loaded with methotrexate on glioblastoma multiforme treatment.
    Pereira NRC; Loiola RA; Rodrigues SF; de Oliveira CP; Büttenbender SL; Guterres SS; Pohlmann AR; Farsky SH
    Int J Nanomedicine; 2018; 13():4563-4573. PubMed ID: 30154652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEGylated squalenoyl-gemcitabine nanoparticles for the treatment of glioblastoma.
    Gaudin A; Song E; King AR; Saucier-Sawyer JK; Bindra R; Desmaële D; Couvreur P; Saltzman WM
    Biomaterials; 2016 Oct; 105():136-144. PubMed ID: 27521616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An innovative hydrogel of gemcitabine-loaded lipid nanocapsules: when the drug is a key player of the nanomedicine structure.
    Moysan E; González-Fernández Y; Lautram N; Béjaud J; Bastiat G; Benoit JP
    Soft Matter; 2014 Mar; 10(11):1767-77. PubMed ID: 24652455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temozolomide-loaded photopolymerizable PEG-DMA-based hydrogel for the treatment of glioblastoma.
    Fourniols T; Randolph LD; Staub A; Vanvarenberg K; Leprince JG; Préat V; des Rieux A; Danhier F
    J Control Release; 2015 Jul; 210():95-104. PubMed ID: 25982679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules.
    Pinton L; Magri S; Masetto E; Vettore M; Schibuola I; Ingangi V; Marigo I; Matha K; Benoit JP; Della Puppa A; Bronte V; Lollo G; Mandruzzato S
    J Nanobiotechnology; 2020 Feb; 18(1):31. PubMed ID: 32066449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy.
    Sasso MS; Lollo G; Pitorre M; Solito S; Pinton L; Valpione S; Bastiat G; Mandruzzato S; Bronte V; Marigo I; Benoit JP
    Biomaterials; 2016 Jul; 96():47-62. PubMed ID: 27135716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival.
    Zhao M; Danhier F; Bastiancich C; Joudiou N; Ganipineni LP; Tsakiris N; Gallez B; Rieux AD; Jankovski A; Bianco J; Préat V
    Int J Pharm; 2018 Sep; 548(1):522-529. PubMed ID: 30017818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological Improvement and Preclinical Evaluation of Methotrexate-Loaded Lipid-Core Nanocapsules in a Glioblastoma Model.
    Figueiró F; de Oliveira CP; Rockenbach L; Mendes FB; Bergamin LS; Jandrey EH; Edelweiss MI; Guterres SS; Pohlmann AR; Battastini AM
    J Biomed Nanotechnol; 2015 Oct; 11(10):1808-18. PubMed ID: 26502643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safe lipid nanocapsule-based gel technology to target lymph nodes and combat mediastinal metastases from an orthotopic non-small-cell lung cancer model in SCID-CB17 mice.
    Wauthoz N; Bastiat G; Moysan E; Cieślak A; Kondo K; Zandecki M; Moal V; Rousselet MC; Hureaux J; Benoit JP
    Nanomedicine; 2015 Jul; 11(5):1237-45. PubMed ID: 25791812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel low molecular weight nanocomposite hydrogel formulation for intra-tumoural delivery of anti-cancer drugs.
    Štaka I; Cadete A; Surikutchi BT; Abuzaid H; Bradshaw TD; Alonso MJ; Marlow M
    Int J Pharm; 2019 Jun; 565():151-161. PubMed ID: 31029659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma.
    Lollo G; Vincent M; Ullio-Gamboa G; Lemaire L; Franconi F; Couez D; Benoit JP
    Int J Pharm; 2015 Nov; 495(2):972-80. PubMed ID: 26428632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan-PLGA mucoadhesive nanoparticles for gemcitabine repurposing for glioblastoma therapy.
    Ramalho MJ; Serra É; Lima J; Loureiro JA; Pereira MC
    Eur J Pharm Biopharm; 2024 Jul; 200():114326. PubMed ID: 38759897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemcitabine-based polymer-drug conjugate for enhanced anticancer effect in colon cancer.
    Liang TJ; Zhou ZM; Cao YQ; Ma MZ; Wang XJ; Jing K
    Int J Pharm; 2016 Nov; 513(1-2):564-571. PubMed ID: 27613255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local delivery of doxorubicin prodrug via lipid nanocapsule-based hydrogel for the treatment of glioblastoma.
    Wang M; Bergès R; Malfanti A; Préat V; Bastiancich C
    Drug Deliv Transl Res; 2024 Dec; 14(12):3322-3338. PubMed ID: 37889402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.